BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 321205)

  • 1. Doxepin up-to-date: a review of its pharmacological properties and therapeutic efficacy with particular reference to depression.
    Pinder RM; Brogden RN; Speight TM; Avery GS
    Drugs; 1977 Mar; 13(3):161-218. PubMed ID: 321205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mianserin: a review of its pharmacological properties and therapeutic efficacy in depressive illness.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1978 Oct; 16(4):273-301. PubMed ID: 359311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tianeptine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depression and coexisting anxiety and depression.
    Wilde MI; Benfield P
    Drugs; 1995 Mar; 49(3):411-39. PubMed ID: 7774514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical application of tricyclic antidepressant pharmacokinetics and plasma levels.
    Amsterdam J; Brunswick D; Mendels J
    Am J Psychiatry; 1980 Jun; 137(6):653-62. PubMed ID: 6990798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the cardiovascular toxicity of three tricyclic antidepressant drugs: imipramine, amitriptyline, and doxepin.
    Brown TC; Leversha A
    Clin Toxicol; 1979 Mar; 14(3):253-6. PubMed ID: 455914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effects of antidepressants on sleep in depressed patients with particular reference to trazodone in comparison to agomelatine, amitriptyline, doxepin, mianserine and mirtazapine].
    Wichniak A; Wierzbicka A
    Pol Merkur Lekarski; 2011 Jul; 31(181):65-70. PubMed ID: 21870714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trazodone: a review of its pharmacological properties and therapeutic use in depression and anxiety.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1981 Jun; 21(6):401-29. PubMed ID: 7018873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doxepin versus imipramine in psychoneurotic depressed patients with sleep disturbance: a double-blind study.
    Finnerty RJ; Goldberg HL; Rickels K
    J Clin Psychiatry; 1978 Dec; 39(12):852-6. PubMed ID: 721790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxepin hydrochloride.
    Hollister LE
    Ann Intern Med; 1974 Sep; 81(3):360-3. PubMed ID: 4604347
    [No Abstract]   [Full Text] [Related]  

  • 10. Which tricyclic for depressed outpatients, imipramine pamoate or amitriptyline?
    Goldberg HL; Finnerty RJ
    Dis Nerv Syst; 1977 Oct; 38(10):785-9. PubMed ID: 332472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular effects of tricyclic antidepressant drugs: therapeutic usage, overdose, and management of complications.
    Marshall JB; Forker AD
    Am Heart J; 1982 Mar; 103(3):401-14. PubMed ID: 7039280
    [No Abstract]   [Full Text] [Related]  

  • 12. Amitriptyline-perphenazine and doxepin in depressed outpatients: a controlled double-blind study.
    Rickels K; Csanalosi I; Werblowsky J; Weise CC; Weinstock R; Brown AS; Winokur A; Von Poelnitz M
    J Clin Psychiatry; 1982 Oct; 43(10):419-22. PubMed ID: 6749826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxepin versus amitriptyline in depression: a sequential double-blind study.
    Grof P; Saxena B; Cantor R; Daigle L; Hetherington D; Haines T
    Curr Ther Res Clin Exp; 1974 May; 16(5):470-6. PubMed ID: 4209062
    [No Abstract]   [Full Text] [Related]  

  • 14. Zimelidine: a review of its pharmacological properties and therapeutic efficacy in depressive illness.
    Heel RC; Morley PA; Brogden RN; Carmine AA; Speight TM; Avery GS
    Drugs; 1982 Sep; 24(3):169-206. PubMed ID: 6215240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nomifensine: A review of its pharmacological properties and therapeutic efficacy in depressive illness.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1979 Jul; 18(1):1-24. PubMed ID: 477572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma levels of tricyclic antidepressants and clinical efficacy: review of the literature -- part II.
    Risch SC; Huey LY; Janowsky DS
    J Clin Psychiatry; 1979 Feb; 40(2):58-69. PubMed ID: 581671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness.
    Benfield P; Heel RC; Lewis SP
    Drugs; 1986 Dec; 32(6):481-508. PubMed ID: 2878798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Family practice management of depression: how to select tricyclic antidepressants.
    Simmons EC
    South Med J; 1979 Jun; 72(6):703-4. PubMed ID: 451657
    [No Abstract]   [Full Text] [Related]  

  • 19. Excess fatality from desipramine in children and adolescents.
    Amitai Y; Frischer H
    J Am Acad Child Adolesc Psychiatry; 2006 Jan; 45(1):54-60. PubMed ID: 16327581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alprazolam, amitriptyline, doxepin, and placebo in the treatment of depression.
    Rickels K; Feighner JP; Smith WT
    Arch Gen Psychiatry; 1985 Feb; 42(2):134-41. PubMed ID: 2858187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.